mitoxantrone has been researched along with Spinal Neoplasms in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Spinal Neoplasms: New abnormal growth of tissue in the SPINE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grönemeyer, DH | 1 |
Seibel, RM | 1 |
1 other study available for mitoxantrone and Spinal Neoplasms
Article | Year |
---|---|
[Microinvasive CT-controlled tumor therapy of soft tissue and skeletal metastases].
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Combined Modality Therapy; Ethanol; Female; Humans; | 1993 |